Nanomix Corporation (NNMX)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2022 | -8.13 Million USD | -43.8% |
| 2021 | -5.66 Million USD | -16.04% |
| 2020 | -4.87 Million USD | -45.89% |
| 2019 | -3.2 Million USD | -78.47% |
| 2018 | -2.63 Million USD | -56.3% |
| 2017 | 264.13 Thousand USD | -0.43% |
| 2016 | -1.72 Million USD | 41.21% |
| 2015 | -1.75 Million USD | 0.0% |
| 2011 | -811.51 Thousand USD | -236.44% |
| 2010 | -241.2 Thousand USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 Q3 | - USD | 0.0% |
| 2023 Q1 | - USD | 100.0% |
| 2023 Q2 | - USD | 0.0% |
| 2022 Q3 | -2.7 Million USD | -71.67% |
| 2022 Q4 | -1.83 Million USD | 32.05% |
| 2022 FY | - USD | -43.8% |
| 2022 Q1 | -1.97 Million USD | -11.65% |
| 2022 Q2 | -1.57 Million USD | 20.2% |
| 2021 FY | - USD | -16.04% |
| 2021 Q2 | -1.31 Million USD | -54.67% |
| 2021 Q1 | -847.69 Thousand USD | 25.98% |
| 2021 Q3 | -1.73 Million USD | -32.07% |
| 2021 Q4 | -1.77 Million USD | -2.22% |
| 2020 Q1 | -1.29 Million USD | 0.0% |
| 2020 FY | - USD | -45.89% |
| 2020 Q2 | -2.09 Million USD | -62.05% |
| 2020 Q3 | -1.14 Million USD | 45.35% |
| 2020 Q4 | -1.14 Million USD | -0.11% |
| 2019 Q3 | -303.43 Thousand USD | -7.75% |
| 2019 FY | - USD | -78.47% |
| 2019 Q2 | -281.62 Thousand USD | 70.41% |
| 2019 Q1 | -951.88 Thousand USD | 0.0% |
| 2018 Q3 | 764.61 Thousand USD | 680.94% |
| 2018 FY | - USD | -56.3% |
| 2018 Q2 | -131.61 Thousand USD | 95.2% |
| 2018 Q1 | -2.74 Million USD | 0.0% |
| 2017 FY | - USD | -0.43% |
| 2017 Q1 | -295.32 Thousand USD | 0.0% |
| 2017 Q2 | -226.98 Thousand USD | 23.14% |
| 2017 Q3 | -971.6 Thousand USD | -328.05% |
| 2016 FY | - USD | 41.21% |
| 2016 Q2 | -178.03 Thousand USD | 30.99% |
| 2016 Q3 | -4.61 Million USD | -2494.95% |
| 2016 Q1 | -257.99 Thousand USD | 0.0% |
| 2015 Q2 | -511.23 Thousand USD | 30.43% |
| 2015 Q3 | -463.22 Thousand USD | 9.39% |
| 2015 Q1 | -734.87 Thousand USD | 0.0% |
| 2015 FY | - USD | 0.0% |
| 2014 Q2 | -1.2 Million USD | 22.59% |
| 2014 Q1 | -1.55 Million USD | 0.0% |
| 2014 Q3 | -1.15 Million USD | 4.38% |
| 2013 Q1 | -662.65 Thousand USD | 0.0% |
| 2013 Q3 | -1.11 Million USD | -115.79% |
| 2013 Q2 | -514.41 Thousand USD | 22.37% |
| 2012 Q3 | -360.86 Thousand USD | -30.73% |
| 2012 Q2 | -276.04 Thousand USD | -9.5% |
| 2012 Q1 | -252.08 Thousand USD | 0.0% |
| 2011 Q3 | -344.38 Thousand USD | -271.93% |
| 2011 Q2 | -92.59 Thousand USD | 0.34% |
| 2011 Q1 | -92.91 Thousand USD | 0.0% |
| 2011 FY | - USD | -236.44% |
| 2010 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| CVR Medical Corp. | - USD | Infinity% |
| BioElectronics Corporation | -274.29 Thousand USD | -2867.577% |
| IR-Med Inc. | -4.89 Million USD | -66.389% |
| Polarean Imaging plc | -11.19 Million USD | 27.291% |
| Medical Supply International USA, Inc. | 456.06 Thousand USD | 1884.802% |
| Avitar, Inc. | -1.66 Million USD | -388.053% |
| AVITA Medical, Inc. | -39.56 Million USD | 79.428% |
| Manhattan Scientifics, Inc. | -1.16 Million USD | -599.293% |
| Össur hf. | 137.38 Million USD | 105.925% |
| Zecotek Photonics Inc. | -3.44 Million USD | -136.469% |
| QHSLab, Inc. | -91.29 Thousand USD | -8816.091% |
| Wellstar International, Inc. | -1.35 Million USD | -500.049% |
| Össur hf. | 137.38 Million USD | 105.925% |
| Bionovate Technologies Corp | - USD | Infinity% |
| EKF Diagnostics Holdings plc | 9.77 Million USD | 183.279% |
| Escalon Medical Corp. | -58.46 Thousand USD | -13823.414% |
| Aurora Spine Corporation | -454.37 Thousand USD | -1691.409% |
| BrainsWay Ltd. | -2.31 Million USD | -252.218% |
| Lattice Biologics Ltd. | - USD | Infinity% |
| NewCardio, Inc. | -9.37 Million USD | 13.216% |
| Hamilton Thorne Ltd. | 5.52 Million USD | 247.416% |
| Vivos Inc. | -2.79 Million USD | -191.419% |
| MicroPort Scientific Corporation | -347.57 Million USD | 97.658% |
| Kelyniam Global, Inc. | -197.69 Thousand USD | -4017.419% |
| REMSleep Holdings, Inc. | -1.66 Million USD | -387.834% |
| CYduct Diagnostics, Inc. | -378.9 Thousand USD | -2048.229% |
| Theraclion SA | -2.05 Million USD | -296.91% |
| Lifeline Biotechnologies, Inc. | - USD | Infinity% |
| Wellness Center USA, Inc. | -707.03 Thousand USD | -1051.262% |
| Positron Corporation | -1.45 Million USD | -460.532% |
| Rafina Innovations Inc. | - USD | Infinity% |
| Electromedical Technologies, Inc. | -1.72 Million USD | -372.724% |
| Lombard Medical, Inc. | -28.06 Million USD | 71.0% |
| ALR Technologies Inc. | -6.4 Million USD | -27.178% |
| Stratec SE | 39.91 Million USD | 120.393% |
| Vycor Medical, Inc. | 100.94 Thousand USD | 8163.726% |
| Heart Tronics, Inc. | -14.85 Million USD | 45.212% |
| Nu-Med Plus, Inc. | -118.25 Thousand USD | -6783.0% |
| Perimeter Medical Imaging AI, Inc. | -13.27 Million USD | 38.692% |
| SANUWAVE Health, Inc. | -9.15 Million USD | 11.06% |
| VMS Rehab Systems, Inc. | -68.55 USD | -11874104.23% |
| Guided Therapeutics, Inc. | -3.12 Million USD | -160.389% |
| Ingen Technologies, Inc. | -8639.00 USD | -94121.171% |
| Odyssey Group International, Inc. | -2.13 Million USD | -280.706% |
| United American Healthcare Corporation | -59 Thousand USD | -13696.215% |
| ECGI Holdings, Inc. | -2.99 Million USD | -172.194% |
| Capital Group Holdings, Inc. | -629.18 Thousand USD | -1193.704% |
| ADM Tronics Unlimited, Inc. | -514.02 Thousand USD | -1483.535% |
| Urologix, Inc. | -6.34 Million USD | -28.307% |
| Rapid Therapeutic Science Laboratories, Inc. | -1.23 Million USD | -556.771% |
| Nexeon MedSystems Inc. | -765.96 Thousand USD | -962.679% |
| SS Innovations International, Inc. | -20.37 Million USD | 60.052% |
| Qualis Innovations, Inc. | -222.81 Thousand USD | -3553.101% |
| Smith & Nephew plc | 1 Billion USD | 100.812% |
| NIOX Group Plc | 11.07 Million USD | 173.496% |
| Fuse Medical, Inc. | 1.83 Million USD | 543.508% |
| Broncus Holding Corporation | -25.19 Million USD | 67.698% |
| Brain Scientific Inc. | -7.93 Million USD | -2.597% |
| Pressure BioSciences, Inc. | -9.39 Million USD | 13.323% |
| Health Logic Interactive Inc. | -18.4 Thousand USD | -44137.864% |